Biological Effect of Soy Isoflavones in the Prevention of Civilization Diseases

Overview

Journal Nutrients

Date 2019 Jul 24

PMID 31330799

Citations 38

Authors

Marzena Pabich

Malgorzata Materska

Affiliations

Soon will be listed here.

Abstract

Scientific advancements in recent years have shed new light on the relationship between diet and human health. Nutrients play an important role in the prevention of many civilization diseases, such as osteoporosis, type II diabetes, hypercholesterolemia, and cardiovascular diseases. The biological activity of natural plant components allows their use in the treatment of various diseases, especially civilization diseases, to be speculated. Special attention is paid to phenolic compounds that have numerous health-promoting properties. Isoflavones, phenolic compounds, are commonly found in legumes, especially in soybeans. Their structural similarity to 17-β-estradiol (E2), the main female sex hormone, allows them to induce estrogenic and antiestrogenic effects by binding to estrogen receptors, and their consumption has been associated with a decreased risk of hormone-related cancers. In addition, numerous epidemiological studies and related meta-analyses suggest that soy consumption may be associated with a lower incidence of certain diseases. However, there are some doubts about the potential effects on health, such as the effectiveness of cardiovascular risk reduction or breast cancer-promoting properties. The purpose of this review is to present the current knowledge on the potential effects of soy isoflavone consumption with regard to civilization diseases.

Citing Articles

The Potential of Plant Extracts Used in Cosmetic Product Applications-Antioxidants Delivery and Mechanism of Actions.

Galbau C, Irimie M, Neculau A, Dima L, Pogacnik da Silva L, Varciu M Antioxidants (Basel). 2024; 13(11).

PMID: 39594566 PMC: 11591253. DOI: 10.3390/antiox13111425.

Renal Health Through Medicine-Food Homology: A Comprehensive Review of Botanical Micronutrients and Their Mechanisms.

Zhao Y, Song J, Feng R, Hu J, Xu H, Ye M Nutrients. 2024; 16(20).

PMID: 39458524 PMC: 11510533. DOI: 10.3390/nu16203530.

S-Equol Ameliorates Menopausal Osteoarthritis in Rats through Reducing Oxidative Stress and Cartilage Degradation.

Hu Y, Huang T, Huang L, Cheng H, Hsieh B, Chang K Nutrients. 2024; 16(14).

PMID: 39064807 PMC: 11280421. DOI: 10.3390/nu16142364.

Royal Jelly and Fermented Soy Extracts-A Holistic Approach to Menopausal Symptoms That Increase the Quality of Life in Pre- and Post-menopausal Women: An Observational Study.

Balan A, Moga M, Neculau A, Mitrica M, Rogozea L, Ifteni P Nutrients. 2024; 16(5).

PMID: 38474777 PMC: 10934315. DOI: 10.3390/nu16050649.

The use of Isoflavones as Lung Cancer Chemoprevention Agents and their Implications in Treatment through Radio Sensitization.

Athanasiou E, Papageorgiou S, Dafni M, Dafni M, Kelesis I, Vasileiou M Curr Med Chem. 2024; 32(2):214-237.

PMID: 38369709 DOI: 10.2174/0109298673278897231229121524.

References

Anderson J, Anthony M, Cline J, Washburn S, Garner S . Health potential of soy isoflavones for menopausal women. Public Health Nutr. 2000; 2(4):489-504. DOI: 10.1017/s1368980099000671. View

Shu X, Jin F, Dai Q, Wen W, Potter J, Kushi L . Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev. 2001; 10(5):483-8. View

Wu A, Wan P, Hankin J, Tseng C, Yu M, Pike M . Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis. 2002; 23(9):1491-6. DOI: 10.1093/carcin/23.9.1491. View

Jayagopal V, Albertazzi P, Kilpatrick E, Howarth E, Jennings P, Hepburn D . Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care. 2002; 25(10):1709-14. DOI: 10.2337/diacare.25.10.1709. View

Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N . Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res. 2002; 17(10):1904-12. DOI: 10.1359/jbmr.2002.17.10.1904. View

Bhathena S, Velasquez M . Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr. 2002; 76(6):1191-201. DOI: 10.1093/ajcn/76.6.1191. View

Mezei O, Banz W, Steger R, Peluso M, Winters T, Shay N . Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr. 2003; 133(5):1238-43. DOI: 10.1093/jn/133.5.1238. View

Li Z, Hong K, Saltsman P, DeShields S, Bellman M, Thames G . Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein. Eur J Clin Nutr. 2005; 59(3):411-8. DOI: 10.1038/sj.ejcn.1602089. View

Zhan S, Ho S . Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr. 2005; 81(2):397-408. DOI: 10.1093/ajcn.81.2.397. View

10.

Rufer C, Glatt H, Kulling S . Structural elucidation of hydroxylated metabolites of the isoflavan equol by gas chromatography-mass spectrometry and high-performance liquid chromatography-mass spectrometry. Drug Metab Dispos. 2005; 34(1):51-60. DOI: 10.1124/dmd.105.004929. View

11.

Thanos J, Cotterchio M, Boucher B, Kreiger N, Thompson L . Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control. 2006; 17(10):1253-61. DOI: 10.1007/s10552-006-0062-2. View

12.

Ho S, Chen Y, Ho S, Woo J . Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial. Menopause. 2007; 14(5):905-12. DOI: 10.1097/GME.0b013e318032b2d3. View

13.

Klein C, King A . Genistein genotoxicity: critical considerations of in vitro exposure dose. Toxicol Appl Pharmacol. 2007; 224(1):1-11. DOI: 10.1016/j.taap.2007.06.022. View

14.

Villegas R, Gao Y, Yang G, Li H, Elasy T, Zheng W . Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am J Clin Nutr. 2008; 87(1):162-7. PMC: 2361384. DOI: 10.1093/ajcn/87.1.162. View

15.

Xiao C . Health effects of soy protein and isoflavones in humans. J Nutr. 2008; 138(6):1244S-9S. DOI: 10.1093/jn/138.6.1244S. View

16.

Charles C, Yuskavage J, Carlson O, John M, Tagalicud A, Maggio M . Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. Menopause. 2008; 16(2):395-400. PMC: 2695501. DOI: 10.1097/gme.0b013e3181857979. View

17.

Jian L . Soy, isoflavones, and prostate cancer. Mol Nutr Food Res. 2008; 53(2):217-26. DOI: 10.1002/mnfr.200800167. View

18.

Cederroth C, Nef S . Soy, phytoestrogens and metabolism: A review. Mol Cell Endocrinol. 2009; 304(1-2):30-42. DOI: 10.1016/j.mce.2009.02.027. View

19.

Czerwiecki L . [Contemporary view of plant antioxidants role in prevention of civilization diseases]. Rocz Panstw Zakl Hig. 2010; 60(3):201-6. View

20.

Beavers D, Beavers K, Miller M, Stamey J, Messina M . Exposure to isoflavone-containing soy products and endothelial function: a Bayesian meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2010; 22(3):182-91. DOI: 10.1016/j.numecd.2010.05.007. View